Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 298

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1A
Chunk 298
---
 be issued upon conversion of working capital loans can demand that the Company register the warrants
and rights included in such units, the shares of common stock issuable upon exercise of such warrants, the shares of common stock included
in such units, and the shares of common stock underlying such rights. The Company will bear the cost of registering these securities.
The registration and availability of such a significant number of securities for trading in the public market may have an adverse effect
on the market price of the Company Common Stock.

The abovementioned risks are specifically relevant to Company’s
recent Equity Line of Credit (“ELOC”) Agreement

In on February 25, 2025 we entered into an equity purchase agreement
and registration rights agreement (taken together, the “ELOC Agreement”) with White Lion GBM Innovation Fund, providing
that the Company has the right, but not the obligation, to require White Lion to purchase, from time to time, up to the lesser of (i)
$80,000,000 in aggregate gross purchase price of newly issued shares of the Company’s common stock, par value $0.0001 per share,
and (ii) the Exchange Cap, in each case, subject to certain limitations and conditions set forth in the Common Stock Purchase Agreement.
A more detailed discussion of this agreement is included in Part II, Item 7, “Management’s Discussion and Analysis of Financial
Condition and Results of Operations – Liquidity and Capital Resources.”

The ELOC Agreement is central to the Company’s business strategy
and financing needs, and therefore central to its risk profile. Depending upon how, when and at what level this facility is utilized by
the Company, the ELOC Agreement could result in significant dilution for existing holders of Company Common Stock as well as having a
potential negative impact upon the market price of such shares. The same and other factors create significant uncertainty as to the Company’s
ability to rely upon, and have access to funds from, the ELOC Agreement facility.

The Amended Bylaws require, to the fullest extent permitted by
law, that derivative actions brought in our name, as applicable, against their respective directors, officers, other employees or stockholders
for breach of fiduciary duty and other similar actions may be brought only in the Court of Chancery in the State of Delaware, which may
have the effect of discouraging lawsuits against our directors, officers, other employees or stockholders, as applicable.

33

The Amended Bylaws provide that unless we consent in writing to